A peer-reviewed study published in Nature Communications found that a strict ketogenic diet rapidly reversed high blood sugar in mice and, when paired with voluntary exercise, restored the aerobic fitness gains that chronic hyperglycemia had blocked. The research, conducted by a team at Virginia Tech’s Fralin Biomedical Research Institute, offers a new angle on a stubborn clinical problem. People with persistently elevated blood sugar often fail to gain the expected cardiovascular benefits from working out. While the findings are limited to a mouse model, they challenge the standard advice to simply eat less fat and exercise more.
How the Experiment Worked
Researchers used a low-dose streptozotocin (STZ) injection model to create chronic hyperglycemia in male mice, pushing their blood glucose above 200 mg/dL, a threshold that mirrors early-stage diabetes in humans. They then split the animals into groups receiving either standard chow or a ketogenic regimen composed mostly of fat. Some mice in each dietary group also had access to running wheels for voluntary exercise.
The ketogenic diet normalized blood glucose within roughly one week. That speed is striking because it did not depend on restoring normal insulin production. Fasting insulin remained about 50% lower in the STZ-treated animals regardless of diet, confirming that the mice still had damaged beta cells. Instead, the diet appeared to bypass the need for insulin-driven glucose disposal by shifting the animals’ primary fuel source to fat and ketone bodies.
To ensure that the glucose-lowering effect was robust, the Virginia Tech group monitored blood sugar repeatedly and used metabolic cage assessments to track food intake and energy expenditure. They also verified that the keto-fed mice entered nutritional ketosis, with circulating ketone bodies rising substantially as carbohydrate intake dropped to nearly zero. This metabolic switch is central to the hypothesis that ketones can stand in for glucose as a major fuel during exercise.
Exercise Gains Returned Once Blood Sugar Dropped
The most consequential finding was what happened when the keto diet was combined with wheel running. Hyperglycemic mice on standard chow that exercised showed blunted improvements in VO2peak, the gold-standard measure of aerobic capacity. Their muscles also failed to undergo the typical remodeling, such as increased mitochondrial density, that healthy mice develop through training. But hyperglycemic mice on the ketogenic diet that ran on wheels regained normal aerobic training responses compared with chow-fed counterparts.
The study’s authors framed this as evidence that high blood sugar itself, not just low insulin, is the primary barrier to training adaptation. They argued that chronic hyperglycemia interferes with muscle signaling pathways that normally respond to exercise, including those that promote mitochondrial biogenesis and capillary growth. Once glucose levels fell on the ketogenic diet, those pathways appeared to reactivate, allowing the mice to increase VO2peak and improve endurance.
The Virginia Tech team noted that conventional wisdom tells patients to exercise and limit fatty foods, yet for people whose blood sugar stays elevated, that advice may be incomplete. In their view, simply adding more workouts on top of uncontrolled hyperglycemia may not deliver the expected cardiovascular payoff. Instead, interventions that directly lower glucose, whether dietary, pharmacologic, or both, could be necessary to unlock the full benefits of training.
Building on Earlier Drug-Based Evidence
This study did not emerge from thin air. The same research group had previously shown that the SGLT2 inhibitor canagliflozin, a diabetes drug that forces the kidneys to excrete excess glucose, produced a similar rescue effect. In that earlier work, canagliflozin lowered blood glucose in STZ-induced hyperglycemic mice and restored the training response with higher aerobic capacity, along with better muscle remodeling outcomes including capillary density and oxidative fiber content.
The ketogenic diet experiment essentially asks whether a dietary intervention can replicate what a pharmaceutical one already demonstrated. The answer, at least in mice, appears to be yes. That parallel is important because it strengthens the case that glucose reduction itself, regardless of the mechanism, is what unlocks training benefits. It also raises a practical question: could diet alone substitute for or complement medications in some patients with early diabetes or prediabetes?
Other preclinical work has begun exploring how different glucose-lowering strategies affect exercise tolerance. For instance, researchers using alternative STZ-based models of hyperglycemia have reported similarly impaired aerobic adaptations, reinforcing the idea that elevated glucose is a common denominator in blunted training responses. Together, these studies suggest that clinicians may need to consider glycemic status when setting expectations for exercise programs in people with metabolic disease.
Ketones May Fuel Exercise Differently
A separate line of preclinical research adds another layer. In keto-adapted mice given supplemental beta-hydroxybutyrate (BHB), the primary ketone body produced during carbohydrate restriction, animals maintained endurance performance despite reduced muscle glycogen. That study reported circulating ketone levels and substrate use during exercise, suggesting that keto-adapted muscles can perform well by burning fat and ketones even when their usual glycogen reserves are depleted.
This matters because one longstanding criticism of ketogenic diets for athletes and active people is that cutting carbohydrates starves muscles of their preferred quick-burning fuel. The emerging mouse data suggest that, at least after an adaptation period, the metabolic shift to ketones can sustain aerobic performance. Whether this holds during high-intensity or anaerobic efforts, which depend more heavily on glycogen, is less clear from the available evidence and will require more targeted testing.
At the molecular level, ketones may act as both fuels and signaling molecules. The Virginia Tech group and others have noted changes in gene expression related to mitochondrial function, oxidative enzymes, and angiogenesis in keto-fed animals. These shifts could help explain why, once blood sugar is controlled, exercise training regains its potency in remodeling muscle and improving cardiovascular fitness.
Risks That Complicate the Picture
Before anyone interprets these results as a blanket endorsement of the keto diet, other mouse research sounds a note of caution. A study published in Cardiovascular Diabetology assessed an extreme ketogenic diet across multiple mouse models, including lean, diet-induced obese, and atherosclerotic contexts, and found that outcomes varied with body weight, blood lipids, and fatty liver. In some models, the diet worsened cardiovascular risk markers even as it improved others, highlighting that the same intervention can have divergent effects depending on baseline metabolic status.
Separately, a University of Utah team reported that mice kept on a long-term ketogenic diet developed severely impaired carbohydrate tolerance once carbohydrates were reintroduced. In that work, led by Amandine Chaix, keto-adapted animals experienced exaggerated blood sugar spikes and sluggish glucose clearance when switched back to even modest carbohydrate feeding, suggesting that chronic carb restriction may leave the system poorly prepared for dietary flexibility.
These findings echo broader concerns about the sustainability and safety of very low-carbohydrate diets, particularly when followed for years. Potential issues include elevated LDL cholesterol, micronutrient gaps, gastrointestinal side effects, and in people with diabetes who use insulin or certain oral medications, a risk of hypoglycemia or ketoacidosis if changes are not carefully supervised. None of these hazards negate the mouse data on restored exercise adaptation, but they underscore the need for nuance.
What It Means—and What It Doesn’t
For now, the Virginia Tech results are best viewed as mechanistic insight rather than a prescription. They show that in mice with STZ-induced hyperglycemia, aggressively lowering blood sugar, whether with a very low-carbohydrate, high-fat diet or with a glucose-wasting drug, restores the muscle’s ability to adapt to aerobic training. That supports the broader principle that controlling glycemia may be a prerequisite for getting full cardiovascular benefit from exercise in the setting of diabetes.
Translating this to humans will require caution. People are not mice, and STZ-induced beta-cell damage does not perfectly mirror human type 1 or type 2 diabetes. Real-world patients also bring varied genetics, comorbidities, medications, and dietary preferences that could shape how they respond to ketogenic eating. Randomized clinical trials would be needed to test whether similar improvements in VO2max and muscle remodeling occur in people with chronic hyperglycemia who adopt a ketogenic diet, and how those changes compare with more moderate carbohydrate restriction or standard diabetes care.
In the meantime, the work adds to a growing body of evidence that “exercise plus glucose control” may be more effective than “exercise alone” for improving cardiovascular fitness in diabetes. It suggests that clinicians should pay close attention to persistent hyperglycemia in patients who seem to hit a plateau in training gains, and that researchers should continue probing how different dietary and pharmacologic strategies interact with exercise. Whether ketogenic diets ultimately find a place as a targeted tool for specific subsets of patients will depend on future human data, and on balancing the clear metabolic benefits seen in mice against the potential long-term risks that are only beginning to come into focus.
More from Morning Overview
*This article was researched with the help of AI, with human editors creating the final content.
